Document Detail


Nonalcoholic Fatty liver disease and metabolic syndrome in hypopituitary patients.
MedLine Citation:
PMID:  19745609     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Increased incidence of cardiovascular mortality and nonalcoholic fatty liver disease (NAFLD) has been reported in hypopituitarism, but previous studies did not correct for obesity in these patients. Therefore, it remained unclear if endocrine deficiency in hypopituitarism is associated with metabolic consequences independent of obesity. This study was designed to determine the burden of cardiovascular disease and NAFLD in hypopituitarism.
METHODS: We performed a retrospective case-control analysis of hypopituitary patients at Veterans Affair Medical center, Memphis, from January 1997 to June 2007. After matching for age, gender, obesity, and race, relevant data were abstracted from the subjects' records to determine the presence of hypopituitarism, cardiovascular risk factors, and fatty liver disease. Cases and controls were characterized by descriptive statistics and compared using chi(2) and Student t tests.
RESULTS: Hypopituitary patients exhibited higher prevalence of hypertension- 88% versus 78% (P < 0.03), hypertriglyceridemia-80% versus 70% (P = 0.05), low high-density lipoprotein cholesterol-84% versus 70% (P < 0.001), and metabolic syndrome-90% versus 71% (P < 0.001). Patients also had higher mean plasma glucose levels-228 +/- 152 versus 181 +/- 83 mg/dL (P < 0.01). Despite higher preponderance of cardiovascular risk factors in hypopituitary patients, prevalence of cardiovascular morbidity was similar in both groups (P > 0.3). Hypopituitary patients had higher elevations in serum aminotransferase levels and hyperbilirubinemia-24% versus 11% (P < 0.01), as well as higher international normalized ratio (INR) and hypoalbuminemia 40% versus 23% (P < 0.01).
CONCLUSIONS: There is an increased prevalence of metabolic syndrome and liver dysfunction consistent with NAFLD in hypopituitarism. Although hypopituitary patients had higher prevalence of cardiovascular risk factors than controls, they were not disproportionately affected by cardiovascular disease.
Authors:
Ebenezer A Nyenwe; Sarah Williamson-Baddorf; Bradford Waters; Jim Y Wan; Solomon S Solomon
Related Documents :
11269449 - Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass...
8456399 - A new prognostic classification for esophageal atresia.
22323779 - Subregional patterns of preferential striatal dopamine transporter loss differ in parki...
18565329 - Elevated serum levels of s-adenosylhomocysteine, but not homocysteine, are associated w...
1559359 - Cardiodepressant drugs and the high mortality rate associated with ischemic hepatitis.
12970199 - Off-pump coronary artery bypass (opcab) surgery reduces risk-stratified morbidity and m...
1506049 - Evaluation of peritoneovenous shunt in refractory cirrhotic ascites in indian patients.
17963339 - The relationship between the left atrial volume and the maximum p-wave and p-wave dispe...
6611839 - Continuous ambulatory peritoneal dialysis: three years' experience.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  The American journal of the medical sciences     Volume:  338     ISSN:  1538-2990     ISO Abbreviation:  Am. J. Med. Sci.     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-09-11     Completed Date:  2009-09-18     Revised Date:  2014-03-25    
Medline Journal Info:
Nlm Unique ID:  0370506     Medline TA:  Am J Med Sci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  190-5     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Cohort Studies
Fatty Liver / epidemiology*,  etiology
Female
Humans
Hypopituitarism / complications*
Male
Metabolic Syndrome X / epidemiology*,  etiology
Middle Aged
Prevalence
Tennessee / epidemiology
Grant Support
ID/Acronym/Agency:
T35 DK007405/DK/NIDDK NIH HHS; T35 DK007405-23/DK/NIDDK NIH HHS; T35-DK-07405-24/DK/NIDDK NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Does poly-N-acetyl glucosamine patch use reduce arteriovenous fistula and graft failure rates in hem...
Next Document:  Effects of (-)doxazosin on histomorphologic and cell apoptotic changes of the hyperplastic prostate ...